Regional Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Potential Role for Dynamic Magnetic Resonance Imaging as an Imaging Biomarker and a Survival Update from Two Prospective Clinical Trials
作者： Ioannis T. Konstantinidis , Richard K. G. Do , David H. Gultekin , Mithat Gönen , Lawrence H. Schwartz
DOI: 10.1245/S10434-014-3649-Y
关键词:
摘要: Background For patients with unresectable intrahepatic cholangiocarcinoma (ICC), treatment options are limited and survival is poor. This study summarizes the long-term outcome of two previously reported clinical trials using hepatic arterial infusion (HAI) floxuridine dexamethasone (with or without bevacizumab) in advanced ICC.
springer.com
sci-hub.se 参考文章(35)
W Mützel, H J Weinmann, M Laniado, Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiological chemistry and physics and medical NMR. ,vol. 16, pp. 167- 172 ,(1984)
William D. Ensminger, Steven Come, Emil Frei, Glenn Steele, Michael Glode, Vic Raso, Andre Rosowsky, David C. Levin, A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Research. ,vol. 38, pp. 3784- 3792 ,(1978)
Gary H. Lyman, Impact of chemotherapy dose intensity on cancer patient outcomes Journal of The National Comprehensive Cancer Network. ,vol. 7, pp. 99- 108 ,(2009) , 10.6004/JNCCN.2009.0009
S De Bruyne, N Van Damme, P Smeets, L Ferdinande, W Ceelen, J Mertens, C Van de Wiele, R Troisi, L Libbrecht, S Laurent, K Geboes, M Peeters, Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases British Journal of Cancer. ,vol. 106, pp. 1926- 1933 ,(2012) , 10.1038/BJC.2012.184
Ghassan K. Abou-Alfa, Philip Johnson, Jennifer J. Knox, Marinela Capanu, Irina Davidenko, Juan Lacava, Thomas Leung, Bolorsukh Gansukh, Leonard B. Saltz, Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. JAMA. ,vol. 304, pp. 2154- 2160 ,(2010) , 10.1001/JAMA.2010.1672
Nancy E. Kemeny, Lawrence Schwartz, Mithat Gönen, Adam Yopp, David Gultekin, Michael I. D’Angelica, Yuman Fong, Dana Haviland, Alexandra N. Gewirtz, Peter Allen, William R. Jarnagin, Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? Oncology. ,vol. 80, pp. 153- 159 ,(2011) , 10.1159/000324704
Yasser Shaib, Hashem El-Serag, The epidemiology of cholangiocarcinoma. Seminars in Liver Disease. ,vol. 24, pp. 115- 125 ,(2004) , 10.1055/S-2004-828889
Nancy Kemeny, Ying Huang, Alfred M. Cohen, Weiji Shi, John A. Conti, Murray F. Brennan, Joseph R. Bertino, Alan D.M. Turnbull, Deidre Sullivan, Jennifer Stockman, Leslie H. Blumgart, Yuman Fong, Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer New England Journal of Medicine. ,vol. 341, pp. 2039- 2048 ,(1999) , 10.1056/NEJM199912303412702
Sun Ah Kim, Jeong Min Lee, Kyoung Bun Lee, Seung Ho Kim, Soon Ho Yoon, Joon Koo Han, Byung Ihn Choi, Intrahepatic Mass-forming Cholangiocarcinomas: Enhancement Patterns at Multiphasic CT, with Special Emphasis on Arterial Enhancement Pattern—Correlation with Clinicopathologic Findings Radiology. ,vol. 260, pp. 148- 157 ,(2011) , 10.1148/RADIOL.11101777
Peter J. Allen, Aviram Nissan, Antonio I. Picon, Nancy Kemeny, Paul Dudrick, Leah Ben-Porat, Joseph Espat, Alexander Stojadinovic, Alfred M. Cohen, Yuman Fong, Philip B. Paty, Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. Journal of The American College of Surgeons. ,vol. 201, pp. 57- 65 ,(2005) , 10.1016/J.JAMCOLLSURG.2005.03.019